Skip to main content

1 Result(s)

within Chapter Remove this filter Jiang Long Remove this filter

and

  1. No Access

    Chapter

    Discovery and Development of the Next-Generation HCV NS3 Protease Inhibitor Glecaprevir

    The early collaboration between Enanta and Abbott/AbbVie on HCV NS3 protease inhibitor program led to the discovery of ABT-450 (paritaprevir), which is a component of two FDA-approved IFN-free DAA combination ...

    Guoqiang Wang, Jun Ma, Li-Juan Jiang… in HCV: The Journey from Discovery to a Cure (2019)